Jiangsu Target Pharma Laboratories

Jiangsu Target Pharma Laboratories is a clinical-stage biopharmaceutical company based in Changzhou, China, specializing in the discovery and development of innovative small molecule therapeutics. The company focuses on high-prevalence metabolic diseases, including type 2 diabetes, non-alcoholic steatohepatitis (NASH), and hyperuricemia/gout. Their research platform emphasizes G-protein coupled receptors (GPCRs) and ion channels as primary drug targets. With a pipeline of several proprietary candidates, Jiangsu Target Pharma aims to address significant unmet medical needs through rigorous medicinal chemistry and translational research.